HealthEquity

Read more
Jon Kessler's photo - President & CEO of HealthEquity

President & CEO

Jon Kessler

CEO Approval Rating

87/100

Founded:

2002

Status:

PublicIndependent CompanyNASDAQHQY

HEALTHEQUITY TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Jon Kessler

President & CEO

- -
1,027
$139.9M
$733.6M
View Profile
1

Thomas P Gibbons

CEO

66/100
51,300
$265.2M
$15.5B
View Profile
2

Alex Cyriac

Co-Founder & CEO

84/100
75
$46.4M
$7M
View Profile
3

Brian Moynihan

Chairman & CEO

60/100
204,489
- -
$84.7B
View Profile
4

Abigail P. Johnson

Chairman & CEO

69/100
47,000
$3.4B
$21B
View Profile
5

William S. Demchak

Chairman & CEO

76/100
53,063
- -
$16.8B
View Profile
6

Alison Rose

CEO

59/100
62,900
- -
$689.7M
View Profile
7

James E Staley

CEO

59/100
83,000
$872.4M
$29.9B
View Profile
8

Charles W. Scharf

President & CEO

58/100
258,700
- -
$74.7B
View Profile
9

Jane Fraser

CEO

59/100
323,000
$1.2B
$70.6B
View Profile
10

Ralph Hamers

CEO

56/100
71,551
$6.6B
$33.2B
View Profile

Missing a competitor? Contribute!

BNY Mellon is seen as one of HealthEquity's biggest rivals. BNY Mellon is headquartered in New York, New York, and was founded in 1784. BNY Mellon competes in the Banks field. BNY Mellon generates 2,129% the revenue of HealthEquity.

Lively is seen as one of HealthEquity's top competitors. Lively was founded in 2012, and its headquarters is in San Francisco, California. Lively operates in the Health Care Services industry. Lively has 952 fewer employees than HealthEquity.

Bank of America is one of HealthEquity's top rivals. Bank of America is a Public company that was founded in Charlotte, North Carolina in 1998. Bank of America competes in the Banks industry. Bank of America has 210,973 more employees vs. HealthEquity.

HealthEquity Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$733.6M

HealthEquity's revenue is the ranked 23th among it's top 10 competitors. The top 10 competitors average 27.9B. Over the last three quarters, HealthEquity's revenue has grown by 2.7%. Specifically, in Q2 2021's revenue was $184.2M; in Q1 2021, it was $364.2M; in Q4 2020, it was $179.4M.

HealthEquity Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Further

Apr 2021

Source »
$500M
Further is a Minnesota-based digital health platform that provides HSA and consumer-directed benefit administration services for individuals and businesses.
Luum

Mar 2021

Source »
undisclosed
Luum is a commute management platform that provides parking and employee commuter benefit administration solutions for corporate organizations.
WageWorks, Inc.

Jun 2019

Source »
$2B
WageWork provides administration solutions for CDB's that includes pre-tax spending accounts, FSA's, HRA's and wellness programs.

These are all the companies that HealthEquity has acquired. HealthEquity has acquired 3 companies and its latest acquisition was Further in Apr 2021. Further is a Minnesota-based digital health platform that provides HSA and consumer-directed benefit administration services for individuals and businesses.

HealthEquity Funding History

Since HealthEquity was founded in 2002, it has participated in 3 rounds of funding. In total HealthEquity has raised $139.9M. HealthEquity's last funding round was on May 2015 for a total of $0

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
May 2015
--

IPO
Jul 2014
$127.4M

Equity
Aug 2011
$12.5M
-

Since HealthEquity was founded in 2002, it has participated in 3 rounds of funding. In total HealthEquity has raised $139.9M. HealthEquity's last funding round was on May 2015 for a total of $0

HealthEquity Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Versantis is a biotechnology company that develops and commercializes therapies for the treatment of liver and pediatric diseases.
$16.1M
Sep 17, 2019
Series B
-
Minoryx Therapeutics develops and commercializes drug therapies for the treatment of orphan genetic diseases.
$25.1M
Sep 25, 2018
Series B
-
$2.7M
Nov 12, 2017
Equity
-
Versantis is a biotechnology company that develops and commercializes therapies for the treatment of liver and pediatric diseases.
$4.5M
Mar 28, 2017
Series A
-
Minoryx Therapeutics develops and commercializes drug therapies for the treatment of orphan genetic diseases.
$22.1M
Oct 13, 2015
Series A
-

These are all the companies that HealthEquity has invested in. HealthEquity has invested 7 companies and its latest investment was Versantis in Sep 17,. Versantis is a biotechnology company that develops and commercializes therapies for the treatment of liver and pediatric diseases.

HealthEquity News

HealthEquity Blogs

HealthEquity Press Releases

HealthEquity Videos

Social Media

HealthEquity Headquarters

15 W Scenic Pointe Drive Suite 100

Draper, Utah84020

801-727-1000

Driving Directions »

Trending Companies

HealthEquity Summary

ABOUT

Overview

HealthEquity provides tools for health savings accounts and other health financial services. HealthEquity was founded in 2002. HealthEquity's headquarters is located in Draper, Utah, USA 84020. It has raised 139.9M in 3 rounds. The latest round was in...

CEO

HealthEquity's President & CEO, Jon Kessler, currently has an approval rating of 87%. HealthEquity's primary competitors are BNY Mellon, Lively & Bank of America.

Frequently Asked Questions about HealthEquity

  1. When was HealthEquity founded?

    HealthEquity was founded in 2002
  2. Who is HealthEquity's CEO?

    HealthEquity's CEO is Jon Kessler
  3. How much revenue does HealthEquity generate?

    HealthEquity generates $733.6M in revenue
  4. How much funding does HealthEquity have?

    HealthEquity has historically raised $139.9M in funding
  5. Where is HealthEquity's headquarters?

    HealthEquity's headquarters is in Draper Utah, USA
  1. How many employees does HealthEquity have?

    HealthEquity has 1,027 employees
  2. What sector does HealthEquity operate in?

    HealthEquity is in Application Software, Fintech
  3. Who are HealthEquity's competitors?

    HealthEquity's top competitors are BNY Mellon, Lively, Bank of America
  4. Who has HealthEquity invested in?

    HealthEquity's has invested in companies such as Versantis, Minoryx, GlyCardial